March 17, 2009 – Twelve-month data from the ATLANTA Trial shows that the CATANIA Coronary Stent System with NanoThin Polyzene-F offers sustained benefit in the treatment of de novo coronary lesions and maximizes endothelialization, while reducing restenosis, thrombogenicity, and the need for long-term dual-antiplatelet therapy.

March 17, 2009 - eCardio Diagnostics has launched an Academic Medicine initiative to provide a tailored offering to university-based health systems, marking the first time an arrhythmia monitoring company has addressed the unique workflow, teaching and research responsibilities of academic medical centers. The eCardio Academic Medicine service offers:

March 16, 2009 - St. Jude Medical Inc. today announced FDA clearance of the newest version of the Merlin.net Patient Care Network (PCN), a secure, Internet-based remote care system for patients with implanted medical devices.

March 16, 2009 - LUMEDX Corp. and Mennen Medical said today they signed a strategic partnership agreement to provide a total, integrated cath lab data solution and seamless stream of hemodynamic cardiovascular patient data to their customers.

March 16, 2009 - TeraRecon reported that it has achieved greater than 10,000 licensed concurrent users globally for its Aquarius advanced visualization solution, and claims that the figure gives the company the largest market share in the direct-to-end-user market for advanced visualization.

March 16, 2009 – Invatec today announced CE-certification of a new coronary balloon, the IN.PACT Falcon paclitaxel-eluting PTCA balloon catheter, which is one of the first drug-eluting balloons designed specifically to treat atherosclerosis in the coronary arteries.

March 16, 2009 – Today the Access to Medical Imaging Coalition (AMIC), a coalition of physician, patient and imaging manufacturer groups, will hold a media conference to unveil a new analysis on Medicare claims data from 1998 – 2007 for advanced imaging services (CT, MR and Nuclear Medicine (including PET).

March 13, 2009 - Details from the DAVID (Dual Chamber and VVI Implantable Defibrillator) II Trial suggest atrial pacing may be considered a safe alternative to ventricular pacing, but affords no clear advantage over a mode that minimizes pacing. The results of the study were published this week in the March 10, 2009, issue of the Journal of the American College of Cardiology (JACC).